Redirect Notice

Looks like you clickedhttps://www.newswire.ca/news-releases/health-canada-approves-imbruvica-r-ibrutinib-plus-rituximab-for-the-treatment-of-patients-with-chronic-lymphocytic-leukemia-cll--834973397.html

If you do not want to visit that page, you can close this browser tab.